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Mutation of a Nuclear Respiratory Factor 2 Binding Site
in the 5′ Untranslated Region of the ADSL Gene in Three Patients
with Adenylosuccinate Lyase Deficiency
S. Marie, V. Race, M.-C. Nassogne, M.-F. Vincent, and G. Van den Berghe
Laboratory of Physiological Chemistry, Christian de Duve Institute of Cellular Pathology, and Universite´ Catholique de Louvain, Brussels
Adenylosuccinate lyase (ADSL; also called “adenylosuccinase”) catalyzes two steps in the synthesis of purine
nucleotides: (1) the conversion of succinylaminoimidazolecarboxamide ribotide into aminoimidazolecarboxamide
ribotide and (2) the conversion of adenylosuccinate into adenosine monophosphate. ADSL deficiency, a recessively
inherited disorder, causes variable—but most often severe—mental retardation, frequently accompanied by epilepsy
and/or autism. It is characterized by the accumulation, in body fluids, of succinylaminoimidazolecarboxamide
riboside and succinyladenosine, the dephosphorylated derivatives of the two substrates of the enzyme. Analysis of
the ADSL gene of three unrelated patients with ADSL deficiency, in whom one of the ADSL alleles displayed a
normal coding sequence, revealed a 549TrC mutation in the 5′ untranslated region of this allele. Measurements
of the amount of mRNA transcribed from the latter allele showed that it was reduced to ∼33% of that transcribed
from the alleles mutated in their coding sequence. Further investigations showed that the 549TrC mutation
provokes a reduction to 25% of wild-type control of promoter function, as evaluated by luciferase activity and
mRNA level in transfection experiments. The mutation also affects the binding of nuclear respiratory factor 2
(NRF-2), a known activator of transcription, as assessed by gel-shift studies. Our findings indicate that a mutation
of a regulatory region of the ADSL gene might be an unusually frequent cause of ADSL deficiency, and they suggest
a role for NRF-2 in the gene regulation of the purine biosynthetic pathway.
Introduction
Adenylosuccinate lyase (ADSL; also called “adenylosuc-
cinase” [Enzyme Commission number 4.3.2.2]) catalyzes
two steps in the synthesis of purine nucleotides: (1) the
conversion of succinylaminoimidazolecarboxamide ri-
botide (SAICAR) into aminoimidazolecarboxamide ri-
botide (AICAR), the eighth step in the de novo synthesis
of IMP, and (2) the conversion of adenylosuccinate (S-
AMP) into adenosine monophosphate (AMP), the second
step in the conversion of inosine monophosphate into
AMP. ADSL deficiency (MIM 103050), first described by
Jaeken and Van den Berghe (1984), is an autosomal re-
cessive disorder characterized by the accumulation, in
body fluids, of succinylaminoimidazolecarboxamide ri-
boside (SAICAriboside) and succinyladenosine (S-Ado),
the dephosphorylated derivatives of the two substrates of
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ADSL. To date, ∼60 patients with ADSL deficiency have
been diagnosed. Most of them display severe mental re-
tardation, often accompanied by epilepsy and/or autism
(Van den Berghe and Jaeken 2001). The ADSL gene has
been mapped to chromosome region 22q13.1-13.2 in hu-
mans (Van Keuren et al. 1987; Delattre et al. 1991; Fon
et al. 1993). It is 23 kb long and was entirely sequenced
by Kmoch et al. (2000) (GenBank accession number
AF106656). The human coding sequence comprises1,452
nucleotides, encoding a protein of 484 amino acids (Eu-
ropean Molecular Biology Laboratory [EMBL] Database
accession number X65867).
Molecular analysis of 31 affected families has re-
vealed the existence of 30 different mutations (Adenylo-
succinate Lyase Mutations Database Home Page). Most
of them are found in compound heterozygous form. The
large majority are missense mutations, among which a
predominant mutation, R426H, is found in 13 families.
A splicing error (Marie et al. 1999) and a nonsense
mutation (Kmoch et al. 2000) have also been identified.
The present article describes the identification, in three
unrelated patients, of the first mutation found in the 5′
UTR of the ADSL gene, as well as its functional eval-
uation as a disease-causing gene.
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Patients, Material, and Methods
Patients
The three patients were from unrelated families, and
they presented with profound psychomotor delay and
convulsions. Diagnosis was based on the detection of
SAICAriboside and S-Ado by HPLC analysis of cere-
brospinal fluid and/or urine. The clinical features of pa-
tient 1, an Italian American girl, have been published
elsewhere (Nassogne et al. 2000). Patients 2 and 3 are
from Norway and Australia, respectively. In all three
patients, one of the ADSL alleles displayed a normal
coding sequence. On the other allele, a missense muta-
tion was found: R426H in patient 1, S447P in patient
2, and P318L (D. M. Cowley and I. McGown, personal
communication) in patient 3. In accordance with find-
ings in other patients (Race et al. 2000), measurements
of the activity of ADSL in cultured skin fibroblasts
showed 33%, 50%, and 28% of control activity
( nmol/min per mg of protein) with S-AMP,2.51 0.17
and 33%, 46%, and 10% of control activity (1.95
nmol/min per mg of protein) with SAICAR, in pa-0.24
tients 1, 2, and 3, respectively.
Cloning and Sequencing
Total RNA was extracted from two 75-cm2 flasks of
cultured fibroblasts from the patients through use of
TRIZOL reagent (Life-Technologies). M-MLV-Reverse
transcriptase (Life-Technologies) was used to obtain the
cDNA. PCR was performed at 64C through use of Pwo
polymerase (Roche) and two ADSL-specific primers: S1,
starting 47 bp upstream of the ATG codon (47 CCGC-
TCTTCCCTGGTCCAGTC 27); and AS1, starting 26
bp downstream of the stop codon (1483 GATTTTCG-
TTTAATTCTCTTCCAACT 1458) (coding sequence
positions are given with respect to EMBL sequence
X65867).
Genomic DNA was extracted from one flask of cul-
tured fibroblasts, using the QIAamp DNA kit from QIA-
gen. Two primers were used to amplify ∼400 bp of the
5′ flanking region of the gene: S2 (398 GAGGGTCTC-
CCTGTGTTGCCCAG 376) and AS2 (34 TCGGG-
CGAACCATGATCGCCTC 13)
PCR products were either cloned in the pBluescript
plasmid (pBS; Stratagene) and sequenced using the Ther-
mosequenase fluorescent labeled primer cycle sequencing
kit (Amersham) with a 4000L automatic sequencer (Li-
Cor), or they were directly sequenced using the CEQ
200 Dye Terminator cycle sequencing kit with a capillary
automatic sequencer from Beckman Coulter.
Measurements of Relative Amounts of ADSL mRNA
Transcribed from the Patients’ Two Alleles
Quantification of ADSL mRNA harboring the 5′
UTR mutation, as compared with ADSL mRNA car-
rying the patients’ missense mutations, was performed
by PCR amplification of specific allele (PASA), as de-
scribed by Bottema and Sommer (1998). For each of
the three patients, two different pairs of oligonucleo-
tides (numbered “1” and “2” below) were used at the
following annealing temperatures: for patient 1, (1)
WT-426 (1300 AAGTAGGCATCAACCTGGATAC
1279) and P1-2, and (2) Mut-426 (1300 AAGTAG-
GCATCAACCTGGATAT 1279) and P1-2, at 68C;
for patient 2, (1) WT-447 (1361 GGCACGACCAG-
TGAAAGAAGA 1341) and P1-2, and (2) Mut-447
(1361 GGCACGACCAGTGAAAGAAGG 1341)
and P1-2, at 70C; for patient 3, (1) WT-318 (975
GGACAGATGCTGTCTGTAGCG955) and P3, and
(2) Mut-318 (975 GGACAGATGCTGTCTGTAG-
CA 955) and P3, at 66C. The sequence of P1-2, used
in the analysis of patients 1 and 2, is558 TTGAAGC-
GTGTCCGAGATGACC 579, and the sequence of
P3, used in the analysis of patient 3, is 370 TT-
CTTAGAAATGCACTTGACCTGCT 394. Amplifi-
cation of ribosomal protein S26 was used as an inter-
nal control, with the following primers (Vincent et al.
1993): 50 TCGTGCCAAAAAGGGCCGCG 69
(sense strand) and 376 GCTCCTTACATGGGCTTT-
GGTGG 354 (antisense strand).
Samples were withdrawn after 18, 21, 24, 27, and 30
cycles of PCR. Reaction products were resolved on 1.5%
agarose gels. Pictures of the gels were scanned, and PCR
products were quantified by densitometry with the NIH
Image program.
Cell Transfection and Luciferase Assays
A series of DNA constructs were prepared in the pGL2-
basic plasmid from Promega, containing the firefly lucif-
erase gene (F-luc) in the absence of any promoter. Various
lengths of the promoter region of the ADSL gene, in-
cluding the 5′ UTR, were inserted in front of the firefly
luciferase reporter gene. Site-directed mutagenesis was
performed by PCR amplification. The 5′ flanking region
cloned into pBS was amplified using Pwo DNA poly-
merase and two back-to-back primers, one of them con-
taining a single modified base to generate one of three
mutants, 49TrC, 46CrT, or 40TrC. The PCR-
amplified plasmids were purified on 0.8% agarose gels
and were ligated after phosphorylation of the 5′ ends with
ATP and polynucleotide kinase. Clones were checked by
sequencing, and the mutated sequences were subcloned
into the pGL2-basic plasmid.
HEK-293 cells were seeded at cells per well53 # 10
16 Am. J. Hum. Genet. 71:14–21, 2002
Figure 1 Sequence analysis of patient 1 DNA (A) and control
DNA (B).
Figure 2 PASA in patient 1. cDNAs from patient 1 (49TrC/
R426H) (A), a heterozygote (WT/R426H) (B), a control (WT/WT)
(C), and a homozygote (R426H/R426H) (D) were amplified by PCR
with one oligonucleotide specific for the WT allele (WT-426) and one
oligonucleotide specific for the mutated allele (Mut-426), as described
in the “Patients, Material, and Methods” section. PCR products were
analyzed at several numbers of cell cycles, as indicated at the top of
the figure. Ribosomal protein S26 was used as an internal control.
in six-well plates. After 24 h, through use of calcium
phosphate precipitation, cells were cotransfected with 2
mg of the pGL2 plasmid, containing the F-luc constructs,
and with 20 ng of the pRL-CMV reference plasmid,
containing the Renilla luciferase gene (R-luc) under the
control of the cytomegalovirus promoter. F-luc and R-
luc activities were assayed 48 h later, through use of the
dual-luciferase reporter assay system from Promega and
a DLR Turner Design luminometer. Luciferase activity
was expressed as the ratio of F-luc and R-luc values.
Similar experiments were performed with NIH-3T3 cells
that were seeded at cells per well in 24-well45 # 10
plates and transfected with 2 mg of F-luc constructs and
20 ng of pRL-CMV.
Gel-Shift Experiments
Nuclear extracts from HEK-293 cells were prepared as
described by Ausubel et al. (2000, pp. 12.1.1–12.1.3).
HeLa cell nuclear extracts were purchased from Promega.
Double strand oligonucleotides were labeled using T4
polynucleotide kinase and g[32P]-ATP. Protein-DNA bind-
ing reactions were performed in a total volume of 20 ml
containing 3 mg of nuclear extract, 1 mg poly(dI-dC), 10
mM Hepes (pH 7.6), 1 mM dithiothreitol, 5 mM MgCl2,
0.1 mM EDTA, 50 mM KCl, 10% glycerol (v/v), and
cpm of 32P-labeled oligonucleotide. Incubation45 # 10
was for 20 min on ice. For competition experiments, 20
or 50 ng of cold oligonucleotide were added at the same
time. Protein-DNA complexes were resolved by electro-
phoresis on 6% native polyacrylamide gels for 3 h at 200
V. Gels were dried and subjected to autoradiography.
Results
Sequence and Mutation Analysis of the 5′ UTR of the
Human ADSL Gene
The putative transcription initiation start point of the
human ADSL gene was localized, 55 nucleotides up-
stream of the ATG codon, by Kmoch et al. (2000). When
we analyzed the 5′ UTR, we found an additional G in
position 51 (fig. 1), bringing its length to 56 bp. Anal-
ysis of 400 bp of the 5′ flanking region of the DNA of
patient 1 revealed a TrC substitution that was 49 bp
upstream of the ATG codon and thus was located in the
5′ UTR. As shown in figure 1, patient 1 is a T/C het-
erozygote at position 49, which contains T in the con-
trol DNA. The 49TrC mutation was also found in
the heterozygous state in the mother’s DNA. The same
mutation was found in patient 2 from Norway and in
patient 3 from Australia, as well as in her father. It was
not found in a series of 121 control DNAs.
Measurements of the Relative Amounts of mRNA
Transcribed from the Two Alleles of the Patients
Since the 49TrC mutation is located too close to the
5′ end of mRNA, oligonucleotides that would be specific
for the mutated allele (49C) or the normal allele (49T)
could not be used. Three different pairs of oligonucleo-
tides, one for each missense mutation—R426H, S447P,
or P318L—were therefore designed, as described in the
“Patients, Material, and Methods” section, so as to match
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Figure 3 Sequence of the 5′ flanking region of the human ADSL
gene. Bases are numbered by reference to the ATG codon. The bold
arrow indicates the start point of the initiation of transcription. Thin
arrows indicate the start points of the different constructs used for
luciferase assay. Potential binding sites for nuclear factors are under-
lined. The core sequence of the tandem NRF-2 sites are double-un-
derlined. Base 49T within the 52/44 NRF-2 site is indicated in
boldface.
Figure 4 Promoter activity of 5′ flanking region of the human
ADSL gene. Lengths of constructions are indicated on the left, and
activities of firefly luciferase are given on the right as a percentage of
the 1,113-bp construct.
perfectly with the normal sequence (WT-oligo) or the mu-
tant sequence (Mut-oligo) ofADSL. In all cases, WT-oligo
amplified the mRNA with mutation 49TrC.
Figure 2 shows the results obtained in the study of
patient 1, who carries mutations 49TrC and R426H,
with the oligonucleotides specifically amplifying her two
alleles. As shown in panel A, distinctly less mRNA was
transcribed from the patient’s49TrC allele (amplified
with WT-426) than from her R426H allele (amplified
with Mut-426). Quantification after 27 and 30 cycles
showed that the amount of mRNA transcribed from the
49TrC allele reached 30% and 35%, respectively, of
that transcribed from the R426H allele. In contrast (fig.
2B), in an individual heterozygous for the R426H mu-
tation, equal amounts of mRNA were transcribed from
the WT and R426H alleles. The specificity of the two
oligonucleotides at 68C is shown in the bottom panels
of figure 2: the cDNA from control cells (C) was am-
plified only with the WT-426 oligonucleotide, and the
cDNA from a patient homozygous for mutation R426H
(D) was amplified only with the Mut-426 oligonucleo-
tide. Results similar to those depicted in panel A were
obtained for patients 2 and 3, with WT- and Mut-447
and with WT- and Mut-318 oligonucleotides, respec-
tively (not illustrated).
Mapping of the Promoter Region of the Human ADSL
Gene
Analysis of the 5′ UTR sequence in the transcription
factor database TRANSFAC showed that mutation
49TrC is located within the consensus sequence
CNCTTCCGGT (core sequence underlined) of a poten-
tial binding site for nuclear respiratory factor 2 (NRF-
2), a stimulatory regulator of transcription (Virbasius et
al. 1993). To test the effect that a mutation of this po-
tential binding site has on promoter function, we first
analyzed the basal promoter activity of the 5′ flanking
region of the ADSL gene.
As shown in figure 3, several potential binding sites
for nuclear factors are found in the 5′ flanking region of
the ADSL gene, including the NRF-2 site at position
52/44. Of note, close to this site, at position 42/
38, a second potential binding site for NRF-2 is found
with the essential core sequence CTTCC. To map pro-
moter activity of the 5′ flanking region of theADSL gene,
four DNA constructs were used. Fragments starting at
positions 1113, 398, 270, or 68 and ending at
position 3, with respect to the ATG codon (fig. 3),
were cloned into the pGL2-basic plasmid for transient
expression in HEK-293 cells. Figure 4 shows promoter
activities obtained with these constructs, measured as
relative light units (firefly luciferase activity/Renilla lu-
ciferase activity). Maximal promoter activity was ob-
tained with the longest (1113 bp) fragment, which
displayed 400-fold more luciferase activity than the
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Figure 5 Effect of site-directed mutagenesis of theADSL 5′ UTR.
Location of mutations, within or outside of the NRF-2 binding site
(underlined), are shown on top. Luciferase activities are expressed as
percentages of the activity of the 398-bp construct without mutation.
Figure 6 Synthetic oligonucleotides used in gel-shift analysis of
the NRF-2 binding site of ADSL. The binding site for NRF-2 is
underlined.
background activity measured with the empty pGL2-
basic vector. Promoter activity decreased to 66% and
43%, respectively, when the 5′ construct was shortened
from 1113 bp to 398 bp and 270 bp. It was re-
duced to 1.7% when the construct was shortened to68
bp, indicating that the minimal promoter is contained
in the 202 bp deleted between the two last constructs.
Strikingly, constructs in which promoter regions were
inserted in reverse orientation (Rev-398 and Rev-270)
showed even higher promoter activities than their equiv-
alent in forward orientation.
Site-Directed Mutagenesis of the Human ADSL
Promoter
To assess the functional significance of the 49TrC
mutation in the 5′ UTR, we performed site-directed mu-
tagenesis of the 398-bp construct. Figure 5 shows that
the presence of the mutation provoked a reduction to
25% of promoter activity as compared with WT in
HEK-293 cells. Similar results were obtained in NIH-
373 cells, with a reduction to 31% of promoter activity
(not illustrated). Mutation of another base located in the
core sequence of the position 52/44 NRF-2 site—
namely, 46CrT—provoked an even more marked re-
duction, to 12%, of promoter activity in HEK-293 cells
(fig. 5). In contrast, mutation 40TrC, located within
the CTTCC core sequence of the second position 42/
38 potential NRF-2 binding site, had no significant
effect. The 49TrC mutation did not affect the activity
of the promoter in reverse orientation (results not
shown). Northern blots showed that, in the cells trans-
fected with the 49TrC mutated construct, the lucif-
erase mRNA level was reduced three- to fourfold (results
not shown).
Gel-Shift Experiments
To further evaluate the implication of the NRF-2 tran-
scription factor in the expression of the ADSL gene, we
performed gel-shift experiments. Synthetic oligonucleo-
tides used in the present study, given in figure 6, were
derived from the ADSL 5′ flanking region, without (WT-
ADSL) or with (Mut-ADSL) the 49TrC mutation, as
well as from the rat cytochrome c oxidase gene (RCO4-
NRF-2). The latter oligonucleotide, which also contains
a functional binding site for NRF-2 (underlined in the
sequence shown in fig. 6) (Virbasius and Scarpulla
1991), serves as a positive control for NRF-2 in the gel-
shift assays.
Figure 7 shows that the labeled WT-ADSL oligonu-
cleotide probe was able to form a specific complex with
a nuclear extract of HEK-293 cells, which was completely
displaced by 20–50 ng of the cold WT-ADSL oligonu-
cleotide. In contrast, the presence of the 49TrC mu-
tation abolished the capacity of the Mut-ADSL oligonu-
cleotide to compete with the WT-ADSL probe, even in
the presence of 50 ng of DNA. As expected, the RCO4-
NRF-2 oligonucleotide was a very good competitor of the
WT-ADSL oligonucleotide probe.
Upon incubation of the three oligonucleotides in the
labeled form with HEK-293 nuclear extracts, WT-ADSL
and RCO4-NRF-2 formed a complex of the same ap-
parent size, whereas Mut-ADSL formed a complex of
larger size (fig. 8). The same results were obtained with
nuclear extracts from HeLa cells (data not shown).
Discussion
In the present study, we show that analysis of the ADSL
gene of three unrelated patients with ADSL deficiency in
whom one of the ADSL alleles displayed a normal coding
sequence revealed a 49TrC mutation in the 5′ UTR of
this allele. Further investigation showed that the mutation
plays a causal role in their disease, most likely by affecting
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Figure 7 Gel-shift analysis of NRF-2 binding site ofADSL. Bind-
ing of nuclear proteins to labeled WT oligonucleotide is shown in the
absence (0 ng) or in the presence of 20 and 50 ng of WT-ADSL,
49TrC mutated ADSL (Mut-ADSL), and cytochrome c oxidase
(RCO4-NRF-2) cold competitor oligonucleotides.
Figure 8 Comparison of protein-DNA complexes formed with
WT and mutated ADSL, as well as with RCO4-NRF-2. Apparent sizes
of protein-DNA complexes formed after incubation of nuclear extracts
with labeled RCO4-NRF-2 (lane 1), WT-ADSL (lane 2), and49TrC
mutated ADSL (lane 3) oligonucleotides are shown.
the binding of NRF-2, a known activator of transcription.
The studies also suggest a role for NRF-2 in the gene
regulation of the purine biosynthetic pathway.
The observations that the 49TrC mutation de-
creased the amount of mRNA transcribed from this al-
lele, to ∼33% of that transcribed from the other allele
(fig. 2A), and reduced luciferase activity to 25% of WT
in transfection experiments (fig. 5) provide a strong in-
dication that, in the patients’ cells, the allele carrying
this mutation produces a lower amount of the ADSL
enzyme protein. Together with the ADSL lesion pro-
voked by the mutation on the other allele, this would
explain the ADSL deficiency.
The finding of reduced amounts of mRNA in both
the studies of transcription and the transfection exper-
iments performed with the 5′ UTR mutation does not
allow us to differentiate between a transcriptional or
translational effect of the mutation. Indeed, decreased
translation of the mRNA might render it less stable.
However, the finding that the 49TrC mutation is lo-
cated within a potential binding site for the activating
transcription factor NRF-2 is an argument in favor of
a transcriptional effect. NRF-2 is a member of the Ets
factor family (LaMarco et al. 1991; Thompson et al.
1991; Wasylyk et al. 1993) and is identical to the pre-
viously characterized GABP and E4TF1 (Virbasius et al.
1993; Suzuki et al. 1998). NRF-2 is known to activate
the transcription of several nuclear and mitochondrial
genes encoding mitochondrial respiratory proteins, such
as cytochrome c oxidase subunits (Virbasius and Scar-
pula 1991; Seelan et al. 1996; Wong-Riley et al. 2000)
and succinate dehydrogenase iron protein (Au and
Scheffler 1998). Components of the mtDNA transcrip-
tion and replication machinery, such as mtTFA, are also
controlled by NRF-2 (Virbasius and Scarpulla 1994).
Of note, in all of these promoters, the NRF-2 binding
site is frequently located within the 5′ UTR, as in ADSL,
or only a few nucleotides upstream of the transcription
initiation site.
Our gel-shift experiments provide a good indication
that NRF-2 is the factor that binds to the ADSL pro-
moter. Indeed, the RCO4-NRF-2 oligonucleotide com-
petes very well with the WT-ADSL oligonucleotide (fig.
7), indicating that they probably bind the same nuclear
factor. The finding that the ADSL oligonucleotide with
the 49TrC mutation is not able to compete with the
wild-type sequence corroborates the functional impor-
tance of the mutation and indicates that the lack of
NRF-2 binding may play a role in the decrease in tran-
scription. The observation that the protein-DNA com-
plex formed with WT-ADSL DNA comigrates with the
complex formed with the RCO4-NRF-2 oligonucleotide
(fig. 8), which was used to purify NRF-2 from HeLa
cells (Virbasius et al. 1993), also indicates binding of
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NRF-2 to the ADSL promoter. The observation that,
in binding assays with nuclear proteins (fig. 8), the oli-
gonucleotide probe with the 49TrC mutation re-
vealed a complex of higher molecular weight suggests
that the mutation might also allow the binding of an
unknown repressing factor.
It has been shown that NRF-2 binds as a dimer to
its site, with one subunit containing the DNA binding
domain and the other subunit modulating its affinity
for DNA (Thompson et al. 1991; Virbasius et al. 1993).
Moreover, the presence of two very proximal NRF-2
sites is a rather frequent situation in genes controlled
by NRF-2 (Seelan et al. 1996; Wong-Riley et al. 2000).
The presence of a tandem site allows the binding of
NRF-2 as a tetramer, resulting in a stronger interaction
between the factor and DNA. In the ADSL 5′ UTR, we
found a second core sequence of the NRF-2 binding
site, CTTCC, at position 42/38, very close to the
52/44 site. This tandem site could thus bind NRF-
2 as a tetramer. However, the observation in the lucif-
erase experiments that mutation 40TrC within this
second core sequence did not significantly affect tran-
scription (fig. 5) leads us to suppose that this second
site is not implicated in the binding of the factor.
In the course of our studies, we also observed that
the ADSL promoter displays bidirectional activity. Di-
vergent transcription has been reported for other genes,
like Surf and collagen genes (Lennard and Fried 1991;
Fischer et al. 1993). Two closely linked genes of the de
novo pathway of purine synthesis—namely, GPAT and
AIRC—are also divergently transcribed in chicken
(Gavalas et al. 1993; Gavalas and Zalkin 1995), human
(Brayton et al. 1994), and rat (Iwahana et al. 1995).
GPAT encodes glutamine 5′-phosphoribosyl-pyrophos-
phate amidotransferase, catalyzing step 1 of the de novo
purine synthesis, and AIRC encodes a bifunctional en-
zyme, 5′-phosphoribosyl-aminoimidazole carboxylase/
5′-phosphoribosyl 4-(N-succininocarboxamide)-5-ami-
noimidazole synthetase, catalyzing steps 6 and 7.
Interestingly, another nuclear respiratory factor, NRF-
1, implicated in the expression of several genes whose
products function in the mitochondria (Evans and Scar-
pulla 1990; Chau et al. 1992), has been shown to play
a key role in the bidirectional transcription of the human
GPAT-AIRC genes (Chen et al. 1997). A potential NRF-
1 binding site was also found in the rat GPAT-AIRC
promoter (Iwahana et al. 1995) but not in the chicken
promoter (Gavalas et al. 1993). Whereas the NRF-1 site
of the GPAT-AIRC promoter was found to be impli-
cated in the transcription in both orientations, this was
not the case for the NRF-2 site in the ADSL promoter,
since we found that mutations in the latter site did not
affect the transcription in the reverse direction. Also of
note, the identity of the neighbor gene of the ADSL
gene is not known, even though the entire sequence of
human chromosome 22 is available.
Taken together, our studies suggest that a mutation
of a regulatory region of the ADSL gene might be an
unusually frequent cause of ADSL deficiency. Indeed,
regulatory mutations account for !1% of all mutation
types (Human Gene Mutation Database), whereas a dis-
ease-causing mutation of the 5′ UTR has now been iden-
tified in 3 of 31 families with the ADSL enzyme defect.
On the other hand, in vertebrates, little is known about
gene regulation in purine nucleotide synthesis. Our ob-
servation that NRF-2 plays a role in the transcription
of ADSL lends further support to the proposal that
nuclear respiratory factors may play a role in the co-
ordination of respiratory metabolism with biosynthetic
and degradative pathways (Seelan et al. 1996; Scarpulla
1997).
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